These conditions constitute the second leading cause of infection-related mortality in the ICU.
Infected individuals usually require hospitalization and may be treated with a number of antibiotics.
Pharmacists can assist in early identification, antimicrobial selection and dosing, and monitoring of response.
Aspergillosis, which is most commonly observed in immunocompromised persons, is a significant cause of morbidity and mortality in this population, with mortality rates as high as 90%.
Genital herpes is a major public-health concern because of its recurrent nature, its ability to be transmitted asymptomatically, and its potential for complications.
Two new IV antibiotics that act against multidrug-resistant bacteria are welcome additions to pharmacologic therapy.
Many patients continue to experience significant discomfort for months or years after ICU discharge.
A multidisciplinary approach is necessary to assist patients in achieving a reduction in pain.
Mucositis—the breakdown of epithelial cells in the gastrointestinal tract—is a common and painful side effect of treatment for many cancer patients.
The National Pain Strategy is a comprehensive population health-level plan that addresses the issue of inadequate pain management in the United States, as well as the national opioid-abuse epidemic.
Oral phosphate binders are widely used in clinical practice for patients with end-stage renal disease.
The FDA has strengthened the warnings regarding cardiovascular risk with NSAID use.
The number of patients in need of hospice and palliative care continues to grow, as do the general population’s knowledge and awareness of the diagnosed conditions that render patients eligible for hospice care services.
Fibromyalgia syndrome, which was first described more than 100 years ago, is defined as chronic, widespread musculoskeletal pain characterized by both somatic and psychological symptoms.
Gliomas are central nervous system tumors that arise from glial cells in the brain or spine.
Electrolyte disturbances and catecholamine release can result in acute cardiovascular changes.
Complications seen with percutaneous coronary intervention led to the development of bare metal stents and, later, drug-eluting stents.
Pharmacists must know how drugs affect the efficacy and safety of these devices.
Cholesterol concentrations in many patients with familial hypercholesterolemia are poorly controlled despite dietary changes and maximum pharmacologic therapy.
Aspirin has long been used for its anti-inflammatory and analgesic properties, and more recently it has been used for its antithrombotic effect in reducing cardiovascular disease risk.
For more articles, please check our archives.